Physician profile
John J Obi
NPI 1851361687
$2,270.83
in general payments reported to CMS, 2019-2025
15 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $396 · 2021: $150 · 2022: $112 · 2023: $303 · 2024: $301 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $391.96 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Tela Bio, INC. | $311.18 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| W. L. Gore & Associates, INC. | $294.21 | 2019-2025 | Gore Enform Preperitoneal Biomaterial |
| Motiva USA, LLC | $162.56 | 2024 | |
| Tepha INC | $159.29 | 2020 | |
| Abbvie INC. | $147.90 | 2023 | |
| Biotissue Holdings INC. | $131.09 | 2023 | |
| Acelrx Pharmaceuticals, INC. | $121.50 | 2020 | |
| Sientra, INC. | $115.31 | 2020 | |
| Allergan, INC. | $114.92 | 2019 | |
| Kci USA, INC. | $114.16 | 2019 | |
| Next Science LLC | $103.01 | 2021 | |
| Galderma Laboratories, L.P. | $52.54 | 2019 | |
| Merz North America, INC. | $27.03 | 2021 | |
| Csl Behring | $24.17 | 2023 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Obi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.